Facilitatory effects of WAY-100635, a 5-HT 1A receptor antagonist, on lordosis in female rats

Miki Kishitake, Korehito Yamanouchi

    Research output: Contribution to journalArticle

    12 Citations (Scopus)

    Abstract

    Effects of the serotonin (5-HT) receptor 1A antagonist, WAY-100635, on lordosis in female rats were examined. Ovariectomized rats were implanted with a silicon tube containing estradiol and behavioral tests were performed. Next, 5, 10 or 20 mg/kg bw WAY-100635 or saline was injected subcutaneously in female rats with a lordosis quotient (LQ) from 10 to 30 and the behavioral test was performed again. As a result, the mean LQs in 10 or 20 mg WAY-100635-treated groups were higher than in the saline-treated group (P < 0.01 and P < 0.05, 10 or 20 mg groups versus saline, respectively). In the experiment on the time-course of change in LQ after injection with 10 mg WAY-100635, the mean LQ was increased (P < 0.01, versus saline) 15 min after the injection and high levels persisted for 1 h. This finding shows that WAY-100635 has the potency to enhance lordosis behavior acutely in female rats with a low estrous state. In order to investigate relationships between the 5-HT 1A receptor and the GABA B receptor in regulating lordosis, 10 mg baclofen, a GABA B receptor agonist, was injected and this was followed 1 h later by the injection of 10 mg/kg WAY-100635. Mean LQ decreased after the injection of baclofen (P < 0.0001, versus placebo-treated control), but the decrease in LQs was not reversed by injection with WAY-100635.

    Original languageEnglish
    Pages (from-to)147-151
    Number of pages5
    JournalNeuroscience Letters
    Volume371
    Issue number2-3
    DOIs
    Publication statusPublished - 2004 Nov 23

    Fingerprint

    Lordosis
    Receptor, Serotonin, 5-HT1A
    Injections
    Baclofen
    GABA-B Receptor Agonists
    GABA-B Receptors
    Serotonin Receptors
    Silicon
    N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide
    Estradiol
    Placebos

    Keywords

    • 5-HT receptor
    • Baclofen
    • Female rats
    • Lordosis
    • WAY-100635

    ASJC Scopus subject areas

    • Neuroscience(all)

    Cite this

    Facilitatory effects of WAY-100635, a 5-HT 1A receptor antagonist, on lordosis in female rats. / Kishitake, Miki; Yamanouchi, Korehito.

    In: Neuroscience Letters, Vol. 371, No. 2-3, 23.11.2004, p. 147-151.

    Research output: Contribution to journalArticle

    Kishitake, Miki ; Yamanouchi, Korehito. / Facilitatory effects of WAY-100635, a 5-HT 1A receptor antagonist, on lordosis in female rats. In: Neuroscience Letters. 2004 ; Vol. 371, No. 2-3. pp. 147-151.
    @article{b3d0d101aa554ad4b73ed5dd7c722d5d,
    title = "Facilitatory effects of WAY-100635, a 5-HT 1A receptor antagonist, on lordosis in female rats",
    abstract = "Effects of the serotonin (5-HT) receptor 1A antagonist, WAY-100635, on lordosis in female rats were examined. Ovariectomized rats were implanted with a silicon tube containing estradiol and behavioral tests were performed. Next, 5, 10 or 20 mg/kg bw WAY-100635 or saline was injected subcutaneously in female rats with a lordosis quotient (LQ) from 10 to 30 and the behavioral test was performed again. As a result, the mean LQs in 10 or 20 mg WAY-100635-treated groups were higher than in the saline-treated group (P < 0.01 and P < 0.05, 10 or 20 mg groups versus saline, respectively). In the experiment on the time-course of change in LQ after injection with 10 mg WAY-100635, the mean LQ was increased (P < 0.01, versus saline) 15 min after the injection and high levels persisted for 1 h. This finding shows that WAY-100635 has the potency to enhance lordosis behavior acutely in female rats with a low estrous state. In order to investigate relationships between the 5-HT 1A receptor and the GABA B receptor in regulating lordosis, 10 mg baclofen, a GABA B receptor agonist, was injected and this was followed 1 h later by the injection of 10 mg/kg WAY-100635. Mean LQ decreased after the injection of baclofen (P < 0.0001, versus placebo-treated control), but the decrease in LQs was not reversed by injection with WAY-100635.",
    keywords = "5-HT receptor, Baclofen, Female rats, Lordosis, WAY-100635",
    author = "Miki Kishitake and Korehito Yamanouchi",
    year = "2004",
    month = "11",
    day = "23",
    doi = "10.1016/j.neulet.2004.08.058",
    language = "English",
    volume = "371",
    pages = "147--151",
    journal = "Neuroscience Letters",
    issn = "0304-3940",
    publisher = "Elsevier Ireland Ltd",
    number = "2-3",

    }

    TY - JOUR

    T1 - Facilitatory effects of WAY-100635, a 5-HT 1A receptor antagonist, on lordosis in female rats

    AU - Kishitake, Miki

    AU - Yamanouchi, Korehito

    PY - 2004/11/23

    Y1 - 2004/11/23

    N2 - Effects of the serotonin (5-HT) receptor 1A antagonist, WAY-100635, on lordosis in female rats were examined. Ovariectomized rats were implanted with a silicon tube containing estradiol and behavioral tests were performed. Next, 5, 10 or 20 mg/kg bw WAY-100635 or saline was injected subcutaneously in female rats with a lordosis quotient (LQ) from 10 to 30 and the behavioral test was performed again. As a result, the mean LQs in 10 or 20 mg WAY-100635-treated groups were higher than in the saline-treated group (P < 0.01 and P < 0.05, 10 or 20 mg groups versus saline, respectively). In the experiment on the time-course of change in LQ after injection with 10 mg WAY-100635, the mean LQ was increased (P < 0.01, versus saline) 15 min after the injection and high levels persisted for 1 h. This finding shows that WAY-100635 has the potency to enhance lordosis behavior acutely in female rats with a low estrous state. In order to investigate relationships between the 5-HT 1A receptor and the GABA B receptor in regulating lordosis, 10 mg baclofen, a GABA B receptor agonist, was injected and this was followed 1 h later by the injection of 10 mg/kg WAY-100635. Mean LQ decreased after the injection of baclofen (P < 0.0001, versus placebo-treated control), but the decrease in LQs was not reversed by injection with WAY-100635.

    AB - Effects of the serotonin (5-HT) receptor 1A antagonist, WAY-100635, on lordosis in female rats were examined. Ovariectomized rats were implanted with a silicon tube containing estradiol and behavioral tests were performed. Next, 5, 10 or 20 mg/kg bw WAY-100635 or saline was injected subcutaneously in female rats with a lordosis quotient (LQ) from 10 to 30 and the behavioral test was performed again. As a result, the mean LQs in 10 or 20 mg WAY-100635-treated groups were higher than in the saline-treated group (P < 0.01 and P < 0.05, 10 or 20 mg groups versus saline, respectively). In the experiment on the time-course of change in LQ after injection with 10 mg WAY-100635, the mean LQ was increased (P < 0.01, versus saline) 15 min after the injection and high levels persisted for 1 h. This finding shows that WAY-100635 has the potency to enhance lordosis behavior acutely in female rats with a low estrous state. In order to investigate relationships between the 5-HT 1A receptor and the GABA B receptor in regulating lordosis, 10 mg baclofen, a GABA B receptor agonist, was injected and this was followed 1 h later by the injection of 10 mg/kg WAY-100635. Mean LQ decreased after the injection of baclofen (P < 0.0001, versus placebo-treated control), but the decrease in LQs was not reversed by injection with WAY-100635.

    KW - 5-HT receptor

    KW - Baclofen

    KW - Female rats

    KW - Lordosis

    KW - WAY-100635

    UR - http://www.scopus.com/inward/record.url?scp=7444260903&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=7444260903&partnerID=8YFLogxK

    U2 - 10.1016/j.neulet.2004.08.058

    DO - 10.1016/j.neulet.2004.08.058

    M3 - Article

    VL - 371

    SP - 147

    EP - 151

    JO - Neuroscience Letters

    JF - Neuroscience Letters

    SN - 0304-3940

    IS - 2-3

    ER -